CME Group Inc. (NASDAQ:CME) Holdings Cut by McKinley Carter Wealth Services Inc.

McKinley Carter Wealth Services Inc. lowered its holdings in CME Group Inc. (NASDAQ:CME) by 7.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,197 shares of the financial services provider’s stock after selling 94 shares during the period. McKinley Carter Wealth Services Inc.’s holdings in CME Group were worth $252,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in the business. OFI Invest Asset Management acquired a new position in CME Group in the third quarter worth approximately $25,000. Northwest Financial Advisors bought a new stake in CME Group during the fourth quarter valued at about $28,000. Harbor Investment Advisory LLC boosted its holdings in CME Group by 966.7% during the fourth quarter. Harbor Investment Advisory LLC now owns 160 shares of the financial services provider’s stock valued at $34,000 after acquiring an additional 145 shares during the period. BKM Wealth Management LLC bought a new stake in CME Group during the fourth quarter valued at about $38,000. Finally, Atticus Wealth Management LLC bought a new stake in shares of CME Group in the third quarter valued at about $40,000. Institutional investors own 87.75% of the company’s stock.

CME Group Stock Performance

Shares of CME stock opened at $209.92 on Tuesday. The firm has a 50-day moving average of $213.11 and a 200-day moving average of $211.36. The company has a market cap of $75.59 billion, a P/E ratio of 23.88, a P/E/G ratio of 5.21 and a beta of 0.48. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.01. CME Group Inc. has a one year low of $175.73 and a one year high of $223.80.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, April 24th. The financial services provider reported $2.50 earnings per share for the quarter, topping analysts’ consensus estimates of $2.44 by $0.06. CME Group had a net margin of 56.84% and a return on equity of 12.45%. The firm had revenue of $1.49 billion during the quarter, compared to analyst estimates of $1.48 billion. During the same quarter last year, the business earned $2.42 earnings per share. The company’s quarterly revenue was up 3.2% on a year-over-year basis. Equities research analysts forecast that CME Group Inc. will post 9.72 EPS for the current fiscal year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 25th. Stockholders of record on Friday, June 7th will be given a $1.15 dividend. The ex-dividend date of this dividend is Friday, June 7th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.19%. CME Group’s dividend payout ratio (DPR) is currently 52.33%.

Insider Activity

In other CME Group news, insider Hilda Harris Piell sold 7,140 shares of CME Group stock in a transaction that occurred on Wednesday, May 8th. The shares were sold at an average price of $210.35, for a total transaction of $1,501,899.00. Following the completion of the sale, the insider now directly owns 29,256 shares in the company, valued at $6,153,999.60. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In other CME Group news, insider Hilda Harris Piell sold 7,140 shares of CME Group stock in a transaction that occurred on Wednesday, May 8th. The shares were sold at an average price of $210.35, for a total transaction of $1,501,899.00. Following the completion of the sale, the insider now directly owns 29,256 shares in the company, valued at $6,153,999.60. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Terry L. Savage sold 2,500 shares of CME Group stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $210.65, for a total transaction of $526,625.00. Following the transaction, the director now directly owns 17,441 shares in the company, valued at $3,673,946.65. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 49,640 shares of company stock worth $10,464,924. 0.30% of the stock is owned by company insiders.

Analyst Ratings Changes

Several research analysts recently issued reports on CME shares. Barclays increased their price target on shares of CME Group from $226.00 to $228.00 and gave the stock an “equal weight” rating in a research report on Thursday, April 25th. JPMorgan Chase & Co. increased their price target on shares of CME Group from $198.00 to $206.00 and gave the company a “neutral” rating in a research note on Thursday, April 25th. Argus raised their price objective on shares of CME Group from $225.00 to $245.00 and gave the company a “buy” rating in a research note on Wednesday, March 6th. Morgan Stanley lifted their price target on shares of CME Group from $222.00 to $225.00 and gave the stock an “equal weight” rating in a research report on Tuesday, April 9th. Finally, Bank of America lifted their price target on shares of CME Group from $209.00 to $216.00 and gave the stock a “neutral” rating in a research report on Thursday, April 25th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, CME Group has an average rating of “Hold” and an average target price of $217.80.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.